Actinium Pharmaceuticals (NYSE:ATNM) Given “Buy” Rating at HC Wainwright
Actinium Pharmaceuticals (NYSE:ATNM – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a research report issued on Monday,Benzinga reports. They presently have a $4.00 target price on the stock. HC Wainwright’s price objective points to a potential upside of 163.16% from the stock’s current price. Separately, StockNews.com upgraded […]
Actinium Pharmaceuticals (NYSE:ATNM – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a research report issued on Monday,Benzinga reports. They presently have a $4.00 target price on the stock. HC Wainwright’s price objective points to a potential upside of 163.16% from the stock’s current price. Separately, StockNews.com upgraded […]
